Inherently vulnerable to viral contamination, biologics rely on animal- or human-derived starting materials and complex manufacturing processes. Albeit rare, viral contamination incidents are ...

Viral diseases pose a significant global health challenge, placing substantial strain on healthcare systems. Accurate identification of viral infections is crucial for monitoring outbreaks, managing ...

Despite recent advancements, many highly sensitive diagnostic tests for viral diseases still require complicated techniques to prepare a sample or interpret a result, making them impractical for point ...

Researchers have developed a new method to detect RNA viruses based on the triplex-forming probe technology. This innovative methodology opens up new options for detecting viruses such as SARS-CoV-2, ...

Back in the bad old days, dealing with DNA and RNA in a lab setting was often fraught with peril. Detection technologies were limited to radioisotopes and hideous chemicals like ethidium bromide, a ...

Despite recent advancements, many highly sensitive diagnostic tests for viral diseases still require complicated techniques to prepare a sample or interpret a result, making them impractical for point ...

A collaborative biosensing system is developed for amplification-free RNA/miRNA detection by integrating Type III CRISPR-Cas10 system with a graphene field-effect transistor (GFET). Continuous ...

Overview of the NAPTUNE detection process. Probe 1 binds to a specific RNA target, where the enzyme APE1 makes a precise cut, initiating a chain reaction. The resulting DNA fragment activates another ...

A bottleneck to enabling widespread access to molecular diagnostics, especially in low- and middle-income countries, has been the high cost and complex logistics associated with rapid point-of-care ...

Clinical diagnostics detects, identifies, and monitors human diseases or health disorders. Accurate and sensitive diagnostic procedures are crucial for precisely identifying a patient’s health ...